Trial intelligence / Profile preview

Systematic Management Approach for Children and Adolescents With Orbital Lymphatic Malformation

NCT07378657Phase 3Recruiting

Sponsor
Ain Shams University
Start
Nov 2025
Primary completion
Nov 2027
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of sirolimus in Lymphatic Malformation (LM), sponsored by Ain Shams University. Started Nov 2025; status: recruiting.

02

Drugs

sirolimus
03

Conditions

Lymphatic Malformation (LM)

Beyond the preview

Go deeper on NCT07378657.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07378657.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call